2006
DOI: 10.1016/j.neures.2006.06.010
|View full text |Cite
|
Sign up to set email alerts
|

Dietary supplementation of arachidonic and docosahexaenoic acids improves cognitive dysfunction

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

11
168
1
6

Year Published

2008
2008
2022
2022

Publication Types

Select...
6
4

Relationship

0
10

Authors

Journals

citations
Cited by 290 publications
(186 citation statements)
references
References 37 publications
11
168
1
6
Order By: Relevance
“…We should note that imbalances of PLA2 have been shown to be opposite between schizophrenia and Alzheimer's disease patients [38,39,69,72,82,86,89], diseases that also present distinct cognitive deficits [90]. Our findings reinforce the positive impact of the chronic use of lithium in memory-even when given at low concentrations that should reduce its cytotoxicity-and suggest that Pla2 may have a role in neurochemical cascades that affect memory.…”
Section: Discussionsupporting
confidence: 68%
“…We should note that imbalances of PLA2 have been shown to be opposite between schizophrenia and Alzheimer's disease patients [38,39,69,72,82,86,89], diseases that also present distinct cognitive deficits [90]. Our findings reinforce the positive impact of the chronic use of lithium in memory-even when given at low concentrations that should reduce its cytotoxicity-and suggest that Pla2 may have a role in neurochemical cascades that affect memory.…”
Section: Discussionsupporting
confidence: 68%
“…There are many similarities between the neural effects of rearing under EC and of chronically administering DHA, or UMP plus DHA. EC rodents exhibit improved spatial memory [8], while administration of DHA improves cognitive impairment in mouse models of mild cognitive dysfunction or in AD [51]. C57BL/6 learning-impaired mice [52] show increased survival of hippocampal cells if exposed to an EC, while DHA prolongs cell survival in retinal photoreceptors [53].…”
Section: Discussionmentioning
confidence: 99%
“…Several clinical studies indicate that oral administration of EPA can improve emotional and cognitive function in schizophrenic patients (Mellor et al, 1995;Arvindakshan et al, 2003a,b). Likewise, AA (Kotani et al, 2006) and DHA (Horrocks and Yeo, 1999) supplementation can improve cognitive dysfunction seen in human disorders such as Alzheimer's disease.…”
Section: Introductionmentioning
confidence: 99%